Vanguard Group’s CARGO Therapeutics CRGX Stock Holding History

Vanguard Group’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,053,200	Closed	-$8.46M	–	4363
2025 Q2	$8.46M	Sell	2,053,200 -24,169	-1%	-$104K	﹤0.01%	2994
2025 Q1	$8.45M	Sell	2,077,369 -7,146	-0.3%	-$47.9K	﹤0.01%	2937
2024 Q4	$30.1M	Buy	2,084,515 +22,286	+1%	+$404K	﹤0.01%	2391
2024 Q3	$38M	Buy	2,062,229 +600,211	+41%	+$10.7M	﹤0.01%	2295
2024 Q2	$24M	Buy	1,462,018 +345,725	+31%	+$6.57M	﹤0.01%	2477
2024 Q1	$24.9M	Buy	1,116,293 +716,868	+179%	+$17.1M	﹤0.01%	2487
2023 Q4	$9.25M	Buy	+399,425	New	+$6.77M	﹤0.01%	2985

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Group's CRGX Position: Q3 2025 in Review

Vanguard Group sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 2,053,200 shares — an estimated $8.46M sold.

Vanguard Group first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $38M in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Vanguard Group reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Vanguard Group sold 2,053,200 CARGO Therapeutics shares in Q3 2025, an estimated $8.46M.
Vanguard Group first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
Vanguard Group's CARGO Therapeutics position peaked at $38M in Q3 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Vanguard Group's 13F filing for Q3 2025, filed 7 Nov 2025.